The vaccines market analysis report has been added to Technavio’s catalog. The report identifies the vaccines market growth potential to grow by USD 28.28 billion from 2021 to 2026. The market is anticipated to witness a health growth at a CAGR of 4.13%.
This growth can be attributed to increased funding for vaccine development and new vaccine launches. However, high cost of vaccine research, development, and manufacturing can hamper the growth of the market during the next few years.
Key companies profiled
Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co. Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Novavax Inc., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE
Market dynamics
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Market Vendor Landscape
The vaccines market is fragmented and the vendors are deploying growth strategies such as forming strategic alliances to increase their product offerings and geographical reach to compete in the market.
Vendors are offering innovative solutions and launching new products to gain the upper hand in the competitive scenario. For instance, Astellas Pharma Inc. offers vaccine namely MAPS vaccine targeted to prevent and reduce the spread of pneumococcal disease.
Some of Top Vaccines Companies:
Astellas Pharma Inc.AstraZeneca PlcBavarian Nordic ASBharat Biotech Ltd.BrightPath Biotherapeutics Co. Ltd.CSL Ltd.Daiichi Sankyo Co. Ltd.Emergent BioSolutions Inc.GlaxoSmithKline PlcGradalis Inc.Inovio Pharmaceuticals Inc.Johnson and JohnsonMerck and Co. Inc.Mitsubishi Chemical Holdings Corp.Novavax Inc.Pfizer Inc.SanofiSerum Institute of India Pvt. Ltd.Takeda Pharmaceutical Co. Ltd.Valneva SE
Vaccines Market Type Outlook (Revenue, USD bn, 2021-2026)
Prophylactic vaccines – size and forecast 2021-2026Therapeutic vaccines – size and forecast 2021-2026
The prophylactic vaccines type segment held the largest vaccines market share in 2021. The segment will continue to account for the highest market share during the forecast period.
Researchers are encouraged to develop new approaches to overcome the limitations that are associated with the current live attenuated influenza vaccines. The advances in live attenuated vaccine development will drive the growth of the segments during the forecast period.
Vaccines Market Geography Outlook (Revenue, USD bn, 2021-2026)
North America – size and forecast 2021-2026Europe – size and forecast 2021-2026Asia – size and forecast 2021-2026Rest of World (ROW) – size and forecast 2021-2026
48% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for vaccines in North America. Market growth in this region will be slower than the growth of the market in the European and Asian regions. The increasing number of immunization programs and strong prevalence of infectious diseases such as influenza, hepatitis A, hepatitis B, HIV, measles, malaria, and tuberculosis, and non-infectious diseases such as cancer will facilitate the vaccines market growth in North America over the forecast period.
Table of Content
1 Executive Summary
1.1 Market overviewExhibit 01: Executive Summary – Chart on Market OverviewExhibit 02: Executive Summary – Data Table on Market OverviewExhibit 03: Executive Summary – Chart on Global Market CharacteristicsExhibit 04: Executive Summary – Chart on Market by GeographyExhibit 05: Executive Summary – Chart on Market Segmentation by TypeExhibit 06: Executive Summary – Chart on Incremental GrowthExhibit 07: Executive Summary – Data Table on Incremental GrowthExhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystemExhibit 09: Parent marketExhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definitionExhibit 11: Offerings of vendors included in the market definition3.2 Market segment analysisExhibit 12: Market segments3.3 Market size 20213.4 Market outlook: Forecast for 2021-2026Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ billion)Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ billion)Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summaryExhibit 17: Five forces analysis – Comparison between2021 and 20264.2 Bargaining power of buyersExhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 20264.3 Bargaining power of suppliersExhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 20264.4 Threat of new entrantsExhibit 20: Threat of new entrants – Impact of key factors in 2021 and 20264.5 Threat of substitutesExhibit 21: Threat of substitutes – Impact of key factors in 2021 and 20264.6 Threat of rivalryExhibit 22: Threat of rivalry – Impact of key factors in 2021 and 20264.7 Market conditionExhibit 23: Chart on Market condition – Five forces 2021 and 2026
5 Market Segmentation by Type
5.1 Market segmentsExhibit 24: Chart on Type – Market share 2021-2026 (%)Exhibit 25: Data Table on Type – Market share 2021-2026 (%)5.2 Comparison by TypeExhibit 26: Chart on Comparison by TypeExhibit 27: Data Table on Comparison by Type5.3 Prophylactic vaccines – Market size and forecast 2021-2026Exhibit 28: Chart on Prophylactic vaccines – Market size and forecast 2021-2026 ($ billion)Exhibit 29: Data Table on Prophylactic vaccines – Market size and forecast 2021-2026 ($ billion)Exhibit 30: Chart on Prophylactic vaccines – Year-over-year growth 2021-2026 (%)Exhibit 31: Data Table on Prophylactic vaccines – Year-over-year growth 2021-2026 (%)5.4 Therapeutic vaccines – Market size and forecast 2021-2026Exhibit 32: Chart on Therapeutic vaccines – Market size and forecast 2021-2026 ($ billion)Exhibit 33: Data Table on Therapeutic vaccines – Market size and forecast 2021-2026 ($ billion)Exhibit 34: Chart on Therapeutic vaccines – Year-over-year growth 2021-2026 (%)Exhibit 35: Data Table on Therapeutic vaccines – Year-over-year growth 2021-2026 (%)5.5 Market opportunity by TypeExhibit 36: Market opportunity by Type ($ billion)
6 Customer Landscape
6.1 Customer landscape overviewExhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentationExhibit 38: Chart on Market share by geography 2021-2026 (%)Exhibit 39: Data Table on Market share by geography 2021-2026 (%)7.2 Geographic comparisonExhibit 40: Chart on Geographic comparisonExhibit 41: Data Table on Geographic comparison7.3 North America – Market size and forecast 2021-2026Exhibit 42: Chart on North America – Market size and forecast 2021-2026 ($ billion)Exhibit 43: Data Table on North America – Market size and forecast 2021-2026 ($ billion)Exhibit 44: Chart on North America – Year-over-year growth 2021-2026 (%)Exhibit 45: Data Table on North America – Year-over-year growth 2021-2026 (%)7.4 Europe – Market size and forecast 2021-2026Exhibit 46: Chart on Europe – Market size and forecast 2021-2026 ($ billion)Exhibit 47: Data Table on Europe – Market size and forecast 2021-2026 ($ billion)Exhibit 48: Chart on Europe – Year-over-year growth 2021-2026 (%)Exhibit 49: Data Table on Europe – Year-over-year growth 2021-2026 (%)7.5 Asia – Market size and forecast 2021-2026Exhibit 50: Chart on Asia – Market size and forecast 2021-2026 ($ billion)Exhibit 51: Data Table on Asia – Market size and forecast 2021-2026 ($ billion)Exhibit 52: Chart on Asia – Year-over-year growth 2021-2026 (%)Exhibit 53: Data Table on Asia – Year-over-year growth 2021-2026 (%)7.6 Rest of World (ROW) – Market size and forecast 2021-2026Exhibit 54: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ billion)Exhibit 55: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ billion)Exhibit 56: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)Exhibit 57: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)7.7 US – Market size and forecast 2021-2026Exhibit 58: Chart on US – Market size and forecast 2021-2026 ($ billion)Exhibit 59: Data Table on US – Market size and forecast 2021-2026 ($ billion)Exhibit 60: Chart on US – Year-over-year growth 2021-2026 (%)Exhibit 61: Data Table on US – Year-over-year growth 2021-2026 (%)7.8 Germany – Market size and forecast 2021-2026Exhibit 62: Chart on Germany – Market size and forecast 2021-2026 ($ billion)Exhibit 63: Data Table on Germany – Market size and forecast 2021-2026 ($ billion)Exhibit 64: Chart on Germany – Year-over-year growth 2021-2026 (%)Exhibit 65: Data Table on Germany – Year-over-year growth 2021-2026 (%)7.9 UK – Market size and forecast 2021-2026Exhibit 66: Chart on UK – Market size and forecast 2021-2026 ($ billion)Exhibit 67: Data Table on UK – Market size and forecast 2021-2026 ($ billion)Exhibit 68: Chart on UK – Year-over-year growth 2021-2026 (%)Exhibit 69: Data Table on UK – Year-over-year growth 2021-2026 (%)7.10 Canada – Market size and forecast 2021-2026Exhibit 70: Chart on Canada – Market size and forecast 2021-2026 ($ billion)Exhibit 71: Data Table on Canada – Market size and forecast 2021-2026 ($ billion)Exhibit 72: Chart on Canada – Year-over-year growth 2021-2026 (%)Exhibit 73: Data Table on Canada – Year-over-year growth 2021-2026 (%)7.11 France – Market size and forecast 2021-2026Exhibit 74: Chart on France – Market size and forecast 2021-2026 ($ billion)Exhibit 75: Data Table on France – Market size and forecast 2021-2026 ($ billion)Exhibit 76: Chart on France – Year-over-year growth 2021-2026 (%)Exhibit 77: Data Table on France – Year-over-year growth 2021-2026 (%)7.12 Market opportunity by geographyExhibit 78: Market opportunity by geography ($ billion)
8 Drivers, Challenges, and Trends
8.1 Market drivers8.2 Market challenges8.3 Impact of drivers and challengesExhibit 79: Impact of drivers and challenges in 2021 and 20268.4 Market trends
9 Vendor Landscape
9.1 Overview9.2 Vendor landscapeExhibit 80: Overview on Criticality of inputs and Factors of differentiation9.3 Landscape disruptionExhibit 81: Overview on factors of disruption9.4 Industry risksExhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors coveredExhibit 83: Vendors covered10.2 Market positioning of vendorsExhibit 84: Matrix on vendor position and classification10.3 Astellas Pharma Inc.Exhibit 85: Astellas Pharma Inc. – OverviewExhibit 86: Astellas Pharma Inc. – Product / ServiceExhibit 87: Astellas Pharma Inc. – Key newsExhibit 88: Astellas Pharma Inc. – Key offerings10.4 AstraZeneca PlcExhibit 89: AstraZeneca Plc – OverviewExhibit 90: AstraZeneca Plc – Product / ServiceExhibit 91: AstraZeneca Plc – Key newsExhibit 92: AstraZeneca Plc – Key offerings10.5 Bavarian Nordic ASExhibit 93: Bavarian Nordic AS – OverviewExhibit 94: Bavarian Nordic AS – Product / ServiceExhibit 95: Bavarian Nordic AS – Key newsExhibit 96: Bavarian Nordic AS – Key offerings10.6 Bharat Biotech Ltd.Exhibit 97: Bharat Biotech Ltd. – OverviewExhibit 98: Bharat Biotech Ltd. – Product / ServiceExhibit 99: Bharat Biotech Ltd. – Key newsExhibit 100: Bharat Biotech Ltd. – Key offerings10.7 BrightPath Biotherapeutics Co. Ltd.Exhibit 101: BrightPath Biotherapeutics Co. Ltd. – OverviewExhibit 102: BrightPath Biotherapeutics Co. Ltd. – Product / ServiceExhibit 103: BrightPath Biotherapeutics Co. Ltd. – Key offerings10.8 CSL Ltd.Exhibit 104: CSL Ltd. – OverviewExhibit 105: CSL Ltd. – Business segmentsExhibit 106: CSL Ltd. – Key newsExhibit 107: CSL Ltd. – Key offeringsExhibit 108: CSL Ltd. – Segment focus10.9 Daiichi Sankyo Co. Ltd.Exhibit 109: Daiichi Sankyo Co. Ltd. – OverviewExhibit 110: Daiichi Sankyo Co. Ltd. – Business segmentsExhibit 111: Daiichi Sankyo Co. Ltd. – Key newsExhibit 112: Daiichi Sankyo Co. Ltd. – Key offeringsExhibit 113: Daiichi Sankyo Co. Ltd. – Segment focus10.10 Emergent BioSolutions Inc.Exhibit 114: Emergent BioSolutions Inc. – OverviewExhibit 115: Emergent BioSolutions Inc. – Product / ServiceExhibit 116: Emergent BioSolutions Inc. – Key newsExhibit 117: Emergent BioSolutions Inc. – Key offerings10.11 GlaxoSmithKline PlcExhibit 118: GlaxoSmithKline Plc – OverviewExhibit 119: GlaxoSmithKline Plc – Business segmentsExhibit 120: GlaxoSmithKline Plc – Key newsExhibit 121: GlaxoSmithKline Plc – Key offeringsExhibit 122: GlaxoSmithKline Plc – Segment focus10.12 Gradalis Inc.Exhibit 123: Gradalis Inc. – OverviewExhibit 124: Gradalis Inc. – Product / ServiceExhibit 125: Gradalis Inc. – Key offerings
11 Appendix
11.1 Scope of the report11.2 Inclusions and exclusions checklistExhibit 126: Inclusions checklist exhibits 127: Exclusions checklist11.3 Currency conversion rates for US$Exhibit 128: Currency conversion rates for US$11.4 Research methodologyExhibit 129: Research methodologyExhibit 130: Validation techniques employed for market sizingExhibit 131: Information sources11.5 List of abbreviationsExhibit 132: List of abbreviations
About Technavio
